BiCity investee company is making its “digital triage” service available free to the public to deal with what it predicts will be a surge in neck and back problems among employees working from home. PhysioMedics, which trades under the name of its PhysioWizard platform, is offering...
An innovative project in Nottingham that converts carbon dioxide into clean animal feed is 1 of 9 pioneering agricultural technology projects set to benefit from £24 million of government funding. Nottingham-based consortium REACT-FIRST will receive over £2 million to generate clean, sustainable food for fish and...
The project will obtain critical data about a new single-cell protein used in fish and poultry feed that is set to sustainably transform the UK’s aquaculture and poultry industries. A ground-breaking carbon recycling project, REACT-FIRST, that is set to transform the UK’s food production systems, has...
As part of their 20 years in business celebrations, Adamson Jones is undertaking a huge challenge to complete a virtual journey from their office at BioCity in Nottingham all the way to the European Patent Office (EPO) in Munich. The 22-strong team will attempt to collectively...
Pioneering life science incubator and business collective, BioCity Group has signed the Time to Change Employer Pledge, making a commitment to changing the way we all think and act about mental health in the workplace. BioCity, which has headquarters in Nottingham and locations in Glasgow and...
BioCity, Nottingham based Worn Again Technologies, the unique polymer recycling technology firm, has today announced that it has secured up to €8 million in new equity capital from investors, including follow-on commitments from two of its existing strategic investors, H&M Group and Sulzer. This announcement comes soon...
Next-generation yeast developer, and BioCity client company Phenotypeca Ltd, has won the competition to develop yeast strains for the production of SARS-CoV-2 antigens to detect who has had COVID-19 in the UK population. This addresses an urgent unmet need by UK diagnostic companies and vaccine...
Lanarkshire business says Alfacyte could halt lung disease and prevent lasting damage in coronavirus patients Lanarkshire-based biotech firm ILC Therapeutics has announced a research partnership with the University of St Andrews to work on a drug which could save the lives of Covid-19 patients. Scientists at ILC believe Alfacyte could be more effective...
This year’s online workshops will also offer teachers the chance to brush up on new science teaching skills. A range of workshops focusing on STEM subjects are set to be made available online for pupils and teachers across Scotland. The Summer STEM Academy, led by the University of...
Cambridge, UK – 9th June 2020 – Cresset Discovery Services, provider of contract research services for early phase discovery, and InoCardia, provider of cardiac safety testing models, are pleased to announce a one year collaboration to develop improved computational methods for cardiac safety assessment. This...